These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29506828)

  • 1. Effect of the vascularized bone components on the survival of vascularized composite allografts.
    Chen J; Zhang D; Zhang T; Chen C; Song Y; Liu S; Su Y; Guo S
    J Surg Res; 2018 Apr; 224():132-138. PubMed ID: 29506828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.
    Siemionow M; Rampazzo A; Gharb BB; Cwykiel J; Klimczak A; Madajka M; Nasir S; Bozkurt M
    Microsurgery; 2016 Nov; 36(8):676-683. PubMed ID: 26990895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats.
    Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK
    Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.
    Cwykiel J; Jundzill A; Klimczak A; Madajka-Niemeyer M; Siemionow M
    Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):13. PubMed ID: 33970329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression.
    Butler PE; Lee WP; van de Water AP; Randolph MA
    Plast Reconstr Surg; 2000 Jun; 105(7):2424-30; discussion 2431-2. PubMed ID: 10845297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.
    Xu H; Ramsey DM; Wu S; Bozulic LD; Ildstad ST
    Transplantation; 2013 Jan; 95(2):301-8. PubMed ID: 23250336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
    Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
    Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
    Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
    Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
    Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
    Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative model of vascularized bone marrow transplant: partial femur transplantation.
    Chen JW; Chen C; Su YJ; Yan L; Wang SP; Guo SZ
    Ann Plast Surg; 2014 Dec; 73(6):710-5. PubMed ID: 24830660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    Chimerism; 2013; 4(1):20-2. PubMed ID: 23712382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
    Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.